Nasdaq stss.

In connection with the offering, the Company will issue 2,248,521 units and pre-funded units at a purchase price of $1.69 per unit priced at-the-market under Nasdaq rules. The pre-funded units will be sold at the same price less the pre-funded warrant exercise price of $0.001. Each unit and pre-funded unit consist of one share of common stock (or pre …

Nasdaq stss. Things To Know About Nasdaq stss.

Sharps Technology Inc. Common Stock (STSS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.WEST COLUMBIA, S.C. and NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery company offering patented, best-in-class syringe products, announced today a …Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like they did in the case of Sharps Technology, Inc. (NASDAQ:STSS), that sends out a ...By Thomas Kerr, CFA NASDAQ:STSS OVERVIEW Sharps Technology, Inc. (NASDAQ:STSS) is a medical device company specializing in drug delivery technology for the pharmaceutical and healthcare markets. The company operates two primary syringe-based platforms which includes pre-filled syringes and smart safety syringes. In November 2022, Sharps entered into an impactful manufacturing and research06/30/2022. 26. 26. New. $0. 1. Back to STSS Overview. Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major ...

High-Value specialized prefillable syringe systems to accelerate revenue growth in 2023 and beyond. Company to launch next generation specialty polymer-based syringe products for the healthcare marketUsually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like they did in the case of Sharps Technology, Inc. (NASDAQ:STSS), that sends out a ...

The latest price target for Sharps Technology ( NASDAQ: STSS) was reported by Aegis Capital on Tuesday, May 9, 2023. The analyst firm set a price target for 16.00 expecting STSS to rise to within ...

Wells Fargo & Company, Private Banking and Investment Banking Arm. 58. US$25.5. 31.82%. no data. Show more. View Information. Uncover the latest insider trading activity for Sharps Technology, Inc. (STSS). Know which insiders are buying and selling along with top shareholders and ownership breakdown.Wells Fargo & Company, Private Banking and Investment Banking Arm. 58. US$25.5. 31.82%. no data. Show more. View Information. Uncover the latest insider trading activity for Sharps Technology, Inc. (STSS). Know which insiders are buying and selling along with top shareholders and ownership breakdown.NEW YORK, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company ...

Is Sharps Technology (NASDAQ:STSS) the best stock in the Surgical & medical instruments industry? Compare top STSS competitors at MarketBeat.

FDA/CE-Mark facility to produce our full range of world-class specialty safety syringesNEW YORK, July 14, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS ...

ORLANDO, FL / ACCESSWIRE / September 29, 2023 / RedChip Companies will air interviews with Sharps Technology, Inc. (NASDAQ:STSS), Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) and American ...Stock Screener Earnings Calendar Sectors Nasdaq | STSS U.S.: Nasdaq Sharps Technology Inc. Watch list NEW Set a price target alert After Hours Last Updated: Oct 26, 2023 6:44 p.m. EDT Delayed...NEW YORK, NY / ACCESSWIRE / April 19, 2022 / Aegis Capital Corp. acted as Sole Bookrunner on a ~$16 Million Initial Public Offering for Sharps Technology, Inc. (NASDAQ:STSS). About Sharps ...Nasdaq: STSS. Price. $0.47. December 1, 2023 3:59 PMETDecember 1, 2023. Volume ... NASDAQ Capital Market : STSS. Sharps Technology Inc. (STSS). $0.470.00(0.04 ...For most intents and purposes, Sharps Technology (NASDAQ: STSS) bears all the signs of a busted IPO. Its $4.25 IPO price barely lasted beyond the opening bell; shares have since fallen to $1.22.

Stock analysis for Sharps Technology Inc (STSS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.NEW YORK, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...As of March 2015, Theranos is a private company and does not have a public stock symbol. The medical technology company has a partnership with the public company, Walgreens, which has a stock symbol of WAG on Nasdaq.Nov 17, 2023 · STSS Sharps Technology Inc Statement of Changes in Beneficial Ownership (4) FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...06/30/2022. 26. 26. New. $0. 1. Back to STSS Overview. Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major ...NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company ...

(STSS) raised $16 million in an initial public offering on Thursday, April 14th 2022. The company issued 3,750,000 shares at a price of $4.25 per share. Who are Sharps Technology's major shareholders?08.06.2022 - NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) - Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), is an innovative medical device company offering patented ...

Nov 17, 2023 · Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering patented, best-in-class syringe products, announces an update on commercialization activities and is highlighted in Med Tech Outlook feature article. 06/30/2022. 26. 26. New. $0. 1. Back to STSS Overview. Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major ... Sharps Technology Inc. (NASDAQ: STSS) has recently made significant strides in the copolymer prefillable syringe market, thanks to a strategic partnership with Nephron Pharmaceuticals Corp. Nephron Pharmaceuticals Corp., a renowned player in contract manufacturing of generic medications and 503B outsourcing, has agreed to a …Apr 14, 2022 · The common stock and warrants are expected to begin trading on The Nasdaq Capital Market on April 14, 2022, under the symbols “STSS” and “STSSW,” respectively. Story continues. The common stock and warrants began trading on The Nasdaq Capital Market on April 14, 2022, under the symbols “STSS” and “STSSW,” respectively. Aegis Capital Corp. acted as the sole book ...Sharps Technology Inc. Common Stock (STSS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.In connection with the offering, the Company will issue 2,248,521 units and pre-funded units at a purchase price of $1.69 per unit priced at-the-market under Nasdaq rules. The pre-funded units will be sold at the same price less the pre-funded warrant exercise price of $0.001. Each unit and pre-funded unit consist of one share of common stock (or pre …Explore Sharps Technology, Inc. with its drug pipeline, therapeutic area, technology platform, 4 news.

Find the latest SEC Filings data for Sharps Technology Inc. Common Stock (STSS) at Nasdaq.com.

Nov 24, 2023 · Sharps Technology (STSS) Insider Trading Activity 2023. S&P 500 4,559.34. DOW 35,390.15. QQQ 389.51. Turned down for a loan, business owners look to family and even crowdsourcing to get money to grow. [Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad) 12 crew members are missing, 1 dead after a cargo ship sinks off ...

Back to STSS Overview. Get up to 10 years of daily historical stock prices & volumes. The "Close/Last" is the “adjust consolidated close price”. Data provided by Edgar Online . The net and ...NEW YORK and WEST COLUMBIA, S.C., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and ...Sharps Technology Inc. Common Stock (STSS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. NEW YORK, April 04, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering ...4,365.98 Home STSS • NASDAQ Sharps Technology Inc Follow Share $0.44 Nov 6, 8:30:00 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to Innovative Eyewear Inc $0.44 LUCY3.33% Bruush Oral...Sharps Technology Inc. Common Stock (STSS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. What's going on at Sharps Technology (NASDAQ:STSS)? Read today's STSS news from trusted media outlets at MarketBeat.Nasdaq: STSS. Price. $0.47. December 1, 2023 3:59 PMETDecember 1, 2023. Volume ... NASDAQ Capital Market : STSS. Sharps Technology Inc. (STSS). $0.470.00(0.04 ...NEW YORK, NY - (NewMediaWire) - September 22, 2023 - Sharps Technology, Inc. (NASDAQ: STSS), is pleased to announce its CEO, Robert Hayes, recently conducted an interview with SmallCapsDaily ...With a clear path to significant revenue growth and near-term profitability, Sharps represents a compelling opportunity for fast-acting investors. Aegis Capital ...SoundThinking, Inc. Common Stock (SSTI) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Feb 6, 2023 · NEW YORK, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...

High-growth Stocks. Return. 235%Sharps Technology (NASDAQ:STSS) Monday filed a prospectus related to the proposed resale of 11.33 million common shares by the selling stockholders.This prospectus is not an offer to sell these ...NEW YORK, April 19, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device company offering patented, best-in-class, single use smart safety syringe products, today announced the closing of its initial public offering of 3,750,000 units at a public offering price of $4.25 …Advertisement Sharps Technology, Inc. (STSS) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 0.4500 +0.0036 (+0.81%) At close: 04:00PM EST …Instagram:https://instagram. brokers in canadasaphire pkkpmh stockshare price gilead Let's have a look at what is happening on the US markets on Wednesday. Below you can find the stocks with an unusual volume in today's session. nikola trucks newsamc taylor swift NEW YORK, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...NEW YORK, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company ... chevron owner Sharps Technology, Inc. Announces Closing of $16 Million Initial Public Offering. (GlobeNewswire) Apr-13-22 09:34PM. Sharps Technology Announces Pricing of Initial Public Offering. (GlobeNewswire) Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative ...Apr 19, 2022 · The common stock and warrants began trading on The Nasdaq Capital Market on April 14, 2022, under the symbols “STSS” and “STSSW,” respectively. Aegis Capital Corp. acted as the sole book ...